Anjali Singh, Aneeka Chatterjee

Stories by Anjali Singh, Aneeka Chatterjee

India's legacy liquor brands raise a toast to growth, reinvention

India's legacy liquor brands raise a toast to growth, reinvention

Rediff.com   21 Sep 2025

By 10 am, Rakshit N Jagdale is already deep into the rhythm of the day, which promises to be a carousel of meetings, calls, and strategic decisions. As managing director of Amrut Distilleries, he balances ritual and ambition, tradition and transformation, like many other legacy players in India's alcoholic beverages sector who are staring at a rosy future.

AHPI, Star Health in spat over cashless service

AHPI, Star Health in spat over cashless service

Rediff.com   15 Sep 2025

If cashless services are suspended, AHPI said, its member hospitals will continue to treat Star Health policyholders, but patients will have to pay upfront and later seek reimbursements directly from the insurer.

Patients to benefit from GST cut, but pharma firms may face margin pressure

Patients to benefit from GST cut, but pharma firms may face margin pressure

Rediff.com   12 Sep 2025

The rationalisation of goods and services tax (GST), announced on Wednesday, directly lowers the cost of everyday medical consumables, and also high-end therapies in oncology and rare diseases, helping reduce out-of-pocket patient expenditure and better adherence to medication.

Why Hospitals Are Spending Money On IT

Why Hospitals Are Spending Money On IT

Rediff.com   11 Sep 2025

60 per cent of hospitals are directing investments towards IT capability building, 50 per cent towards business intelligence tools and data lakes, and a significant share into AI-led use cases such as clinical documentation (72 per cent), decision support systems (64 per cent) and imaging (60 per cent).

EV makers hope for festive spark to light up sales

EV makers hope for festive spark to light up sales

Rediff.com   27 Aug 2025

India may see its busiest EV festive season in 2025 with SUVs, luxury cars and scooters set to launch, but rare-earth supply bottlenecks risk delaying rollouts.

It's Pouring Car Discounts!

It's Pouring Car Discounts!

Rediff.com   18 Aug 2025

For hatchbacks and sedans, offers range between Rs 40,000 and Rs 80,000 while SUVs and multi-purpose vehicles carry benefits exceeding Rs 1 lakh.

US tariffs threaten to derail India's affordable housing market recovery

US tariffs threaten to derail India's affordable housing market recovery

Rediff.com   12 Aug 2025

The US's recent 50 per cent tariff on Indian exports will have a trickledown effect on India's affordable housing, potentially derailing demand as well as supply in this segment, according to experts. Pointing to worker incomes and jobs in micro, small and medium enterprises (MSMEs), and small and medium enterprises (SMEs) that typically make up majority of the customer base of affordable housing, would take a hit in the near terms due to the tariff change, further crippling India's affordable housing sector, already reeling from the impact of the Covid-19 pandemic.

Indian Pharma Majors Ready With Weight Loss Drugs

Indian Pharma Majors Ready With Weight Loss Drugs

Rediff.com   12 Aug 2025

Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.

EV car sales nearly double in July; two-wheeler demand slips: FADA data

EV car sales nearly double in July; two-wheeler demand slips: FADA data

Rediff.com   10 Aug 2025

Retail sales of electric passenger vehicles (ePVs) nearly doubled in July 2025, surging 93 per cent year-on-year (Y-o-Y) to 15,528 units, even as overall passenger vehicle (PV) retail volumes declined marginally. In contrast, electric two-wheeler (e2W) sales dropped by 4.3 per cent to 102,973 units, according to the Federation of Automobile Dealers Associations (Fada) data.

Oben Electric's Rorr EZ Sigma e-bike gets an upgrade

Oben Electric's Rorr EZ Sigma e-bike gets an upgrade

Rediff.com   7 Aug 2025

The model is powered by Oben's in-house LFP (lithium iron phosphate) battery technology, which the company claims offers greater temperature tolerance and lifespan.

Auto firms align dispatches with retail demand amid stock pileup

Auto firms align dispatches with retail demand amid stock pileup

Rediff.com   4 Aug 2025

Manufacturers of passenger vehicles (PVs) in the first half of the calendar year (2025) reported a modest 0.5 per cent year-on-year increase in wholesale dispatches, while retail sales grew 2.5 per cent for the same period, reflecting a calibrated approach by automakers amid elevated dealership inventories and cautious consumer sentiment. According to the Society of Indian Automobile Manufacturers (Siam), dispatches rose marginally to 2.16 million units, up from 2.15 million units a year earlier.

Mahindra e-SUVs Can Now Drive Upto 500 km On Single Charge

Mahindra e-SUVs Can Now Drive Upto 500 km On Single Charge

Rediff.com   11 Jul 2025

Customers who have already booked earlier variants will also have the option to upgrade to the 79 kWh battery version.

Gross office space leasing soars 5% in Q2 of 2025: Cushman & Wakefield

Gross office space leasing soars 5% in Q2 of 2025: Cushman & Wakefield

Rediff.com   8 Jul 2025

Fuelled by the global capability centre (GCC) boom, gross leasing of office space across top eight cities soared 5 per cent to touch 21.4 million square feet (msf) in the second quarter of calendar year 2025, according to Cushman & Wakefield's Q2 India Office Market report.

Siddaramaiah Flags Vaccine-Heart Link

Siddaramaiah Flags Vaccine-Heart Link

Rediff.com   2 Jul 2025

Karnataka Chief Minister Siddaramaiah alleged that the rushed approval and distribution of the COVID-19 vaccine may be a contributing factor to cardiac arrest deaths, citing several international studies that recently suggested a possible link between the vaccines and a rise in heart attacks.

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Indian pharma eyes US gains as $63.7 bn patent cliff nears

Rediff.com   30 Jun 2025

The Indian pharmaceutical industry is likely to benefit from a major wave of patent expiries in the US, as small-molecule drugs worth $63.7 billion are expected to go off-patent between 2025-29, a 65 per cent rise over the previous five years, according to a report by Antique stock broking limited.

Hospitals Boost IT Spend to Fight Cyber Threats

Hospitals Boost IT Spend to Fight Cyber Threats

Rediff.com   20 Jun 2025

The growing caution among hospitals is being driven by a rise in double-extortion ransomware attacks, AI-enabled phishing, deepfake fraud, and vulnerabilities in connected medical devices.

TaMo eyes 40% CV, 16% PV market share

TaMo eyes 40% CV, 16% PV market share

Rediff.com   17 Jun 2025

Tata Motors (TaMo) is aiming to gain market share across its passenger vehicle (PV) and commercial vehicle (CV) businesses - targeting a 40 per cent share in CVs and a 16 per cent share in PVs by 2027. Meanwhile, it has already achieved earnings before interest, tax, depreciation, and amortisation (Ebitda) breakeven in its electric vehicle (EV) business at 1.2 per cent (up 830 basis points), ahead of its target of 2025-26 (FY26).

Rare earth inventories may run dry by mid-July

Rare earth inventories may run dry by mid-July

Rediff.com   13 Jun 2025

Inventories of rare earth magnets used in critical automotive components - particularly electric vehicle (EV) traction motors and power steering systems - could run dry by mid-July this year, according to rating agency Icra.

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

HDFC Bank to pursue legal remedies against Mehta family of Lilavati Trust

Rediff.com   9 Jun 2025

HDFC Bank on Sunday said that it will "pursue all lawful remedies" to recover public funds and address the retaliatory actions taken by the Mehta family of the Lilavati Kirtilal Mehta Medical (LKMM) Trust, which has filed a complaint against the bank's managing director (MD) & chief executive officer (CEO) Sashidhar Jagdishan alleging financial fraud.

'Ready To Launch 5 products In 18 Months'

'Ready To Launch 5 products In 18 Months'

Rediff.com   5 Jun 2025

'We recently launched Yesintek in the immunology space.'